| Market Cap | ₹226.99 CrSmall Cap |
|---|---|
| Revenue Qtr | ₹17.06 Cr+26.19% YoY |
| P/E TTM | 1520.4Sector 55.2 |
| RSI | 45.25Neutral Zone |
Key highlights
- 11th branch at Erode, Tamil Nadu, commenced operations on October 30, 2026
- Inaugurated by Tamil Nadu Minister for Handlooms and Textiles, Thiru M. Vijay Balaji
- Company reported Q1 FY27 operating revenue of ₹17.06 crore
- Net profit for the June 2026 quarter grew 12.65% year-on-year to ₹0.61 crore
- Expansion aligns with management's goal to add 4-5 centers across South India
New Facility Launch in Western Tamil Nadu
Lotus Eye Hospital and Institute Ltd has expanded its clinical footprint with the opening of its 11th branch in Erode, Tamil Nadu. The facility began operations on October 30, 2026, following a high-profile inauguration attended by Thiru M. Vijay Balaji, the Minister for Handlooms and Textiles, and local Members of the Legislative Assembly from Erode West and Modakkurichi.
Thiru K.A. Sengottaiyan, Minister for Revenue and Disaster Management, also graced the event virtually. The leadership team, including Managing Director Ms.
Sangeetha Sundaramoorthy and Director Dr. K. S.
Ramalingam, was present to mark the commercial activation of the new center.
Strategic Footprint and Network Coverage
- Erode Branch: Newest facility located in a key healthcare hub of Tamil Nadu
- Salem Center: Operations located at Brindhavan Road, Fairlands
- Tirupur Facility: Established presence at Kamaraj Road, Thennampalayam
- Mettuppalayam Branch: Situated on the Coimbatore Main Road hub
- Kerala Operations: Multiple centers operating in Kochi at SA Road and Mulanthuruty
- Regional Hubs: Additional branches active in Karur and Gobichettipalayam
Financial Performance and Growth Targets
The expansion follows a period of significant top-line growth for the company. In the quarter ended June 30, 2026, Lotus Eye Hospital reported revenue of ₹17.06 crore, a 25.34% increase from the previous quarter. Operating profit margins stood at 17.26% for the same period.
While the current P/E ratio of 1520.41 is elevated relative to the sector average of 52.34, the company is focusing on a long-term rollout of 4 to 5 additional centers. Management has previously indicated a target EBITDA margin of 20% to 25% as newly launched branches reach their 18 to 24-month operational breakeven phase.
Corporate Acknowledgement
We extend our sincere gratitude to all our stakeholders for their continued trust, valuable contributions and unwavering support in strengthening the Companys growth and advancing the legacy of the Company.
What to watch next
- Declaration of Q2 FY27 financial results scheduled by November 14, 2026
- Updates on the planned rollout of 4-5 additional centers across Tamil Nadu and Kerala
- Breakeven progress of the Erode branch over the next 18 to 24 months
| Share price | ₹109.15 |
|---|---|
| Market capitalisation | ₹226.99 Cr |
| Revenue (annual) | ₹53.71 Cr |
| Net profit (annual) | ₹0.08 Cr |
| Revenue (latest quarter) | ₹17.06 Cr+25.34% vs previous quarter |
| Net profit (latest quarter) | ₹0.61 Cr+292.08% vs previous quarter |
| P/E (TTM) | 1520.41×Sector 52.34× |
| Promoter holding | 40.14%0.00% QoQ |
| FII holding | 0%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Lotus Eye Hospital and Institute Ltd announcing the opening of its 11th branch in Erode. Market figures from a third-party data provider.
